S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 83 200 KRW -2.92% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ST Pharm Co Ltd
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Short-Term Debt
â‚©20.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Short-Term Debt
â‚©542B
CAGR 3-Years
N/A
CAGR 5-Years
43%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Short-Term Debt
â‚©1.7B
CAGR 3-Years
100%
CAGR 5-Years
50%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Short-Term Debt
â‚©0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Short-Term Debt
â‚©11.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Short-Term Debt
â‚©16.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ST Pharm Co Ltd
Glance View

Market Cap
1.6T KRW
Industry
Life Sciences Tools & Services

ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2016-06-23. is a Korea-based company principally engaged in manufacture of pharmaceutical products. The firm's products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
97 768.06 KRW
Undervaluation 15%
Intrinsic Value
Price
S

See Also

What is ST Pharm Co Ltd's Short-Term Debt?
Short-Term Debt
20.9B KRW

Based on the financial report for Sep 30, 2024, ST Pharm Co Ltd's Short-Term Debt amounts to 20.9B KRW.

What is ST Pharm Co Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 1Y
-3%

Over the last year, the Short-Term Debt growth was -3%.

Back to Top